This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Are we Loading Our Patients With Sodium During Hemodialysis Treatments?

This study has been completed.
Information provided by (Responsible Party):
Renal Research Institute Identifier:
First received: October 13, 2011
Last updated: October 18, 2011
Last verified: October 2011
The objectives of the data search is to find out if there is correlation between pre, post serum sodium concentration, dialysate sodium concentration, interdialytic weight gain and associated changes in pre and post systolic and diastolic blood pressure, mean arterial pressure, number of blood pressure medications and adherence to 3 times per week dialysis, mortality.

Renal Failure

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective

Further study details as provided by Renal Research Institute:

Enrollment: 10000
Study Start Date: January 2001
Study Completion Date: October 2011
Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years to 88 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Hemodialysis patients at Renal Research Institute and Fresenius clinics

Inclusion Criteria:

  • Hemodialysis patient
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01454193

United States, New York
Renal Research Institute
New York, New York, United States, 10128
Sponsors and Collaborators
Renal Research Institute
Principal Investigator: Peter Kotanko, MD Renal Research Institute
  More Information

Responsible Party: Renal Research Institute Identifier: NCT01454193     History of Changes
Other Study ID Numbers: 078-08
Study First Received: October 13, 2011
Last Updated: October 18, 2011

Additional relevant MeSH terms:
Renal Insufficiency
Kidney Diseases
Urologic Diseases processed this record on September 21, 2017